Brinzolamide/Brimonidine Tartrate has 9 known drug interactions based on U.S. FDA drug labeling data. Notable interactions include combinations with Alcohol, Aspirin (High-Dose), Barbiturates. Patients taking Brinzolamide/Brimonidine Tartrate should inform their healthcare provider of all current medications — including over-the-counter drugs and supplements — to avoid potentially harmful combinations. Data sourced from OpenFDA and the NIH National Library of Medicine.
- Total
- 9
- Moderate
- 8
Moderate (8)
- Brinzolamide/Brimonidine Tartrate + Alcohol— Potential additive or potentiating effect with CNS depressants. Specific interaction studies not conducted.
- Brinzolamide/Brimonidine Tartrate + Aspirin (High-Dose)— May produce acid-base and electrolyte alterations. Rare instances reported with oral carbonic anhydrase inhibitors combi…
- Brinzolamide/Brimonidine Tartrate + Barbiturates— Potential additive or potentiating effect with CNS depressants. Specific interaction studies not conducted.
- Brinzolamide/Brimonidine Tartrate + Cardiac Glycosides— Brimonidine may reduce blood pressure; caution advised when used with cardiac glycosides.
- Brinzolamide/Brimonidine Tartrate + Mao Inhibitors— Potential for additive effect on systemic effects of carbonic anhydrase inhibition. Concomitant administration not recom…
- Brinzolamide/Brimonidine Tartrate + Monoamine Oxidase Inhibitors (Maois)— May theoretically interfere with brimonidine metabolism and potentially increase systemic side effects such as hypotensi…
- Brinzolamide/Brimonidine Tartrate + Sedatives— Potential additive or potentiating effect with CNS depressants. Specific interaction studies not conducted.
- Brinzolamide/Brimonidine Tartrate + Topical Local Anesthetics— Potential additive or potentiating effect with CNS depressants. Specific interaction studies not conducted.